Recent Company News

• 09:57 PM ET Feb 10, 2026
  

  OneSource Specialty Pharma receives SFDA approval for generic Ozempic (semaglutide) in Saudi Arabia (INR 1193.00, 0.00)

• 04:38 AM ET Feb 05, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:52 AM ET Feb 05, 2026
  

  StreetAccount Summary - European pre-market trading update

• 12:33 PM ET Feb 04, 2026
  

  Brookfield Private Capital discloses it does not intend to make an offer for Hikma Pharmaceuticals (1632.0000p, 0)

• 07:03 AM ET Jan 19, 2026
  

  Hikma Pharmaceuticals announces launch of Enoby and Xtrenbo in the US (1549.0000p, -21)

• 03:28 PM ET Jan 16, 2026
  

  StreetAccount Summary - Politics of the Market preview: week of 19-Jan

• 02:46 PM ET Jan 16, 2026
  

  Supreme Court grants order to hear appeal of Hikma v Amarin (skinny label case) ($14.93, +0.03)

• 06:04 PM ET Jan 06, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 12:02 PM ET Jan 06, 2026
  

  Barclays upgrades BAYN.GR, NOVN.SW, ROG.SW; downgrades BIM.FP, DIA.IM, GSK.LN, others

• 06:45 AM ET Dec 15, 2025
  

  Banks, luxury, travel/leisure the best performers; healthcare, retail and tech the main laggards: